Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas

Patient-Derived Glioma Models: From Patients to Dish to Animals

(2019) Cintia Carla da Hora et al.   Cells

Cell line-based xenograft mouse model of paediatric glioma stem cells mirrors the clinical course of the patient

(2018) Susanna Larsson et al.   CARCINOGENESIS

NKG2D and Its Ligands: “One for All, All for One”

(2018) Alessandra Zingoni et al.   Frontiers in Immunology

Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy

(2018) Michele Patrizii et al.   Frontiers in Oncology

Editorial: Harnessing the Power of Patient Derived Models of Cancer

(2018) Sharon R. Pine et al.   Frontiers in Oncology

The clinical use of IDH1 and IDH2 mutations in gliomas

(2018) Alberto Picca et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

Failure of a patient-derived xenograft for brain tumor model prepared by implantation of tissue fragments

(2016) Kyung-Min Kim et al.   Cancer Cell International

Origin of the U87MG glioma cell line: Good news and bad news

(2016) Marie Allen et al.   Science Translational Medicine

Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods

(2015) Nicolette G. Alkema et al.   Scientific Reports

Galectin 1 Proangiogenic and Promigratory Effects in the Hs683 Oligodendroglioma Model Are Partly Mediated through the Control of BEX2 Expression

(2015) Marie Le Mercier et al.   NEOPLASIA

Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

(2014) M. Hidalgo et al.   Cancer Discovery

The Clinical Relevance of Cancer Cell Lines

(2013) J.-P. Gillet et al.   JNCI-Journal of the National Cancer Institute

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010

(2013) Q. T. Ostrom et al.   NEURO-ONCOLOGY

A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1

(2013) Barbara Klink et al.   PLoS One

Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In Situ

(2013) Kyeung Min Joo et al.   Cell Reports

Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG

(2013) Anna C Navis et al.   Acta Neuropathologica Communications

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

(2011) Yoko S DeRose et al.   NATURE MEDICINE

Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar

(2010) Xi Fei et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy

(2008) Joshua Z. Press et al.   GYNECOLOGIC ONCOLOGY